# Dermata Therapeutics, Inc.: Form 8-K, filed Mar 20, 2023

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: 8-K
- Filed: 2023-03-20
- Accepted by EDGAR: Mar 20, 2023, 16:36 ET
- Period: 2023-03-16
- Accession: 0001654954-23-003181
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000165495423003181/drma_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000165495423003181/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000165495423003181/drma_8k.htm

Filed Mar 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001654954-23-003181. Last ingested by Listed: Nov 11, 2026, 00:26 ET. No prices; not investment advice.
